Results for this period
First quarter1 July 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The special demand from existing customers to stockpile inventory in the same period of the previous year disappeared following the termination of the business activities of 株式会社ビービーラボラトリーズ. In the corporate healthcare support business, contracts with new customers increased, while in the mail-order business, the company promoted upselling to higher-margin products and more efficient use of advertising and sales promotion expenses.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 July 2026–30 September 2026 |
| Net Sales | ¥785 million (YoY -44.5%) |
| Operating profit | ¥51 million (YoY -59.9%) |
| Ordinary income | ¥59 million (YoY -55.7%) |
| Profit attributable to owners of the parent | ¥40 million (YoY -51.2%) |
| Net income per share | ¥1.57 |
| Equity ratio | End of the current fiscal period 89.3% / End of previous period 89.2% |
| Total assets | ¥6,591 million |
| Net assets | ¥5,888 million |
| Full-year earnings forecast | Net Sales ¥3,270 million (YoY -15.5%) / Operating profit ¥300 million (YoY +8.8%) / Ordinary income ¥310 million (YoY +7.7%) / Profit attributable to owners of the parent ¥250 million (YoY +17.8%) |
| Annual Dividend Forecast | ¥10 → ¥10（0.0%） |
| Segment revenue | Biometric assessment systems ¥51,750 thousand (YoY -48.7%) / Corporate healthcare support ¥235,918 thousand (YoY +2.5%) / Healthcare platform ¥494,910 thousand (YoY -54.3%) |
| Segment profit | Biometric assessment systems ¥12,801 thousand (YoY -4.5%) / Corporate healthcare support ¥42,330 thousand (YoY +12.4%) / Healthcare platform ¥72,441 thousand (YoY -54.9%) |
| Orders received and order backlog | Orders received ¥63 million / Order backlog ¥350 million |
| Depreciation and amortization | ¥3,477 thousand |
| Impairment loss | Not applicable |
| Breakdown of extraordinary income (loss) | Not applicable |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Not disclosed / Excluded Number of companies 1 / Company name 株式会社ビービーラボラトリーズ |
| Material subsequent events | At a meeting of the Board of Directors held on 12 November 2026, the company resolved to acquire up to 1,500,000 treasury shares, with a total acquisition price of up to ¥300,000 thousand, through market purchases from 13 November 2026 to 31 May 2027. The purposes are to enhance shareholder returns, improve capital efficiency and use the shares for future M&A and capital and business alliances, among others. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No (target audience: none) |
| Issued Shares at Period-End | 26,158,200 |
| Treasury Shares at Period-End | 2 |
| Factors Behind Changes in Business Performance | The special demand from existing customers to stockpile inventory in the same period of the previous year disappeared following the termination of the business activities of 株式会社ビービーラボラトリーズ. In the corporate healthcare support business, contracts with new customers increased, while in the mail-order business, the company promoted upselling to higher-margin products and more efficient use of advertising and sales promotion expenses. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the same period of the previous year, existing customers stockpiled inventory ahead of the termination of the business activities of 株式会社ビービーラボラトリーズ, creating special demand. In the current period, that special demand disappeared following the termination of the company's business activities. In the corporate healthcare support business, contracts with new customers increased, while in the mail-order business for health supplements, the company promoted upselling to higher-margin products and more efficient use of advertising and sales promotion expenses.